Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Source-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 17, 2025
- Income
- $45,000.00
- Expenses
- Not reported
- Registrant
- EAST END GROUP, LLC
- Client
- ALVOGEN
- Filing UUID
- a22846bf-7b05-4a84-8ec6-c184e538a9ca
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Section 232 investigation into pharmaceuticals and unfair trade practices.
Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.